Literature DB >> 18291594

Lithium blocks stress-induced changes in depressive-like behavior and hippocampal cell fate: the role of glycogen-synthase-kinase-3beta.

R Silva1, A R Mesquita, J Bessa, J C Sousa, I Sotiropoulos, P Leão, O F X Almeida, N Sousa.   

Abstract

Mood disorders are the most common psychiatric disorders. Although the mechanisms implicated in the genesis of mood disorders are still unclear, stress is known to predispose to depression, and recently, studies have related hippocampal neurogenesis and apoptosis to depression. In the present study we first examined the balance between cell birth-death in the hippocampus and subventricular zone (SVZ) of pre-pubertal and adult rats subjected to chronic-mild-stress (CMS). CMS led to increased corticosterone secretion and induced depressive-like symptoms (assessed in the forced-swimming test); these endocrine and behavioral effects were paralleled by decreased hippocampal, but not SVZ, cell proliferation/differentiation and by increased apoptotic rate. In order to determine if lithium, a known mood stabilizer with antidepressant properties, could prevent the stress-induced events, we analyzed the same parameters in a group of rats treated with lithium during the stress exposure period (CMS+Li) and observed that the hormonal, behavioral and cell turnover effects of CMS were abrogated in these animals. Subsequently, to search for possible pathways through which CMS and lithium influence behavior, cell fate and synaptic plasticity, we analyzed the expression of glycogen-synthase-kinase-3beta (GSK-3beta), as well as some of its downstream targets (B-cell-CLL/lymphoma2-associated athanonege (BAG-1) and synapsin-I). CMS increased GSK-3beta and decreased synapsin-I and BAG-1 expression in the hippocampus. Interestingly, co-administration of lithium precluded the CMS-induced effects in GSK-3beta, synapsin-I and BAG-1 expression. Our observation that specific inhibition of this kinase with AR-A014418 blocked the effects of CMS in depressive-like behavior and in BAG-1 and synapsin-I expression confirmed the involvement of the GSK-3beta pathway in stress-induced effects. In summary, these results reveal that lithium, by regulating the activity of GSK-3beta, prevents the deleterious effects of stress on behavior and cellular functions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18291594     DOI: 10.1016/j.neuroscience.2007.12.026

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  62 in total

Review 1.  Depression, antidepressants, and neurogenesis: a critical reappraisal.

Authors:  Nicola D Hanson; Michael J Owens; Charles B Nemeroff
Journal:  Neuropsychopharmacology       Date:  2011-09-21       Impact factor: 7.853

2.  Analysis of target genes regulated by chronic electroconvulsive therapy reveals role for Fzd6 in depression.

Authors:  Bhavya Voleti; Keith Q Tanis; Samuel S Newton; Ronald S Duman
Journal:  Biol Psychiatry       Date:  2011-09-19       Impact factor: 13.382

Review 3.  Does lithium prevent Alzheimer's disease?

Authors:  Orestes V Forlenza; Vanessa J de Paula; Rodrigo Machado-Vieira; Breno S Diniz; Wagner F Gattaz
Journal:  Drugs Aging       Date:  2012-05-01       Impact factor: 3.923

Review 4.  Neurobiology of chronic mild stress: parallels to major depression.

Authors:  Matthew N Hill; Kim G C Hellemans; Pamela Verma; Boris B Gorzalka; Joanne Weinberg
Journal:  Neurosci Biobehav Rev       Date:  2012-07-07       Impact factor: 8.989

5.  The antidepressant-like effect of guanosine is dependent on GSK-3β inhibition and activation of MAPK/ERK and Nrf2/heme oxygenase-1 signaling pathways.

Authors:  Priscila B Rosa; Luis E B Bettio; Vivian B Neis; Morgana Moretti; Isabel Werle; Rodrigo B Leal; Ana Lúcia S Rodrigues
Journal:  Purinergic Signal       Date:  2019-11-25       Impact factor: 3.765

6.  Hippocampal glycogen synthase kinase 3β is critical for the antidepressant effect of cyclin-dependent kinase 5 inhibitor in rats.

Authors:  Gang Li; Ting Liu; Xiangqian Kong; Lei Wang; Xing Jin
Journal:  J Mol Neurosci       Date:  2014-02-22       Impact factor: 3.444

7.  Lithium, but not fluoxetine or the corticotropin-releasing factor receptor 1 receptor antagonist R121919, increases cell proliferation in the adult dentate gyrus.

Authors:  Nicola D Hanson; Charles B Nemeroff; Michael J Owens
Journal:  J Pharmacol Exp Ther       Date:  2011-01-10       Impact factor: 4.030

Review 8.  Genomic and epigenomic mechanisms of glucocorticoids in the brain.

Authors:  Jason D Gray; Joshua F Kogan; Jordan Marrocco; Bruce S McEwen
Journal:  Nat Rev Endocrinol       Date:  2017-09-01       Impact factor: 43.330

9.  Synergistic and additive effects of enriched environment and lithium on the generation of new cells in adult mouse hippocampus.

Authors:  Evelin L Schaeffer; Fabiana G Cerulli; Hélio O X Souza; Sergio Catanozi; Wagner F Gattaz
Journal:  J Neural Transm (Vienna)       Date:  2014-02-20       Impact factor: 3.575

10.  Glycine site N-methyl-D-aspartate receptor antagonist 7-CTKA produces rapid antidepressant-like effects in male rats.

Authors:  Wei-Li Zhu; Shen-Jun Wang; Meng-Meng Liu; Hai-Shui Shi; Ruo-Xi Zhang; Jian-Feng Liu; Zeng-Bo Ding; Lin Lu
Journal:  J Psychiatry Neurosci       Date:  2013-09       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.